BR9507768A - Composição farmacêutica - Google Patents
Composição farmacêuticaInfo
- Publication number
- BR9507768A BR9507768A BR9507768A BR9507768A BR9507768A BR 9507768 A BR9507768 A BR 9507768A BR 9507768 A BR9507768 A BR 9507768A BR 9507768 A BR9507768 A BR 9507768A BR 9507768 A BR9507768 A BR 9507768A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA943740 | 1994-05-27 | ||
PCT/GB1995/001152 WO1995032737A1 (en) | 1994-05-27 | 1995-05-22 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9507768A true BR9507768A (pt) | 1997-09-02 |
Family
ID=25583939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9507768A BR9507768A (pt) | 1994-05-27 | 1995-05-22 | Composição farmacêutica |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0760680A1 (pt) |
JP (1) | JPH10500982A (pt) |
AU (1) | AU2531295A (pt) |
BR (1) | BR9507768A (pt) |
CA (1) | CA2190598A1 (pt) |
WO (1) | WO1995032737A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA959469B (en) * | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
IT1283029B1 (it) * | 1996-05-17 | 1998-04-03 | Resa Farma | Composizioni farmaceutiche a base di diclofenac |
PT831790E (pt) * | 1995-06-07 | 2003-07-31 | Elan Drug Delivery Ltd | Metodos para a incorporacao de modo estavel de substancias no interior de matrizes secas de vidro expandido e composicoes atraves deles obtidas |
AU5774796A (en) * | 1995-06-13 | 1997-01-09 | Dyer, Alison Margaret | Pharmaceutical compositions containing lornoxicam and cyclod extrin |
IT1294205B1 (it) * | 1997-07-23 | 1999-03-24 | Farmigea Spa | Procedimento per la solubilizzazione in acqua e in veicoli acquosi di sostanze farmacologicamente attive |
US8231899B2 (en) * | 1998-09-10 | 2012-07-31 | Nycomed Danmark Aps | Quick release pharmaceutical compositions of drug substances |
CA2343148C (en) | 1998-09-10 | 2005-11-15 | Nycomed Danmark A/S | Quick release pharmaceutical compositions of drug substances |
ITMI20012749A1 (it) * | 2001-12-21 | 2003-06-21 | Chiesi Farma Spa | Procedimento per la preparazione mediante trattamento con microonde di composti di inclusione tra farmaco e ciclodestrine e prodotti ottenut |
CN100518831C (zh) * | 2002-08-15 | 2009-07-29 | 刘云清 | 固体纳米药物及其制备方法 |
JO3352B1 (ar) | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
CA2647348A1 (en) | 2006-03-28 | 2007-10-04 | Javelin Pharmaceuticals, Inc. | Formulations of low dose diclofenac and beta-cyclodextrin |
EP2394641A1 (en) | 2010-05-30 | 2011-12-14 | Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi | Pharmaceutical formulations of lornoxicam |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT52263B (de) * | 1911-04-22 | 1912-02-26 | Jean Baptiste Feilner | Verfahren zur Herstellung von photographischen Kombinationsnegativen. |
HU176215B (en) * | 1978-01-27 | 1981-01-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1 |
JPS5920230A (ja) * | 1982-07-19 | 1984-02-01 | チバ−ガイギ−・アクチエンゲゼルシヤフト | ピルプロフエン含有薬剤 |
DE3346123A1 (de) * | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
YU43290B (en) * | 1986-11-13 | 1989-06-30 | Lek Tovarna Farmacevtskih | Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine |
GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
FR2647343B1 (fr) * | 1989-05-24 | 1994-05-06 | Rhone Poulenc Sante | Nouvelle forme pharmaceutique poreuse et sa preparation |
EP0491812A4 (en) * | 1989-09-14 | 1992-11-04 | Australian Commercial Research & Development Limited | Drug delivery compositions |
FR2660195B1 (fr) * | 1990-03-28 | 1994-10-07 | Crinex Sa Laboratoires | Composition pharmaceutique a macher, antiinflammatoire et/ou analgesique. |
ATE196426T1 (de) * | 1991-06-21 | 2000-10-15 | Takeda Chemical Industries Ltd | Zyklodextrin-zusammensetzung enthaltend fumagillol-derivate |
GB9207990D0 (en) * | 1992-04-10 | 1992-05-27 | Smithkline Beecham Plc | Pharmaceutical composition |
-
1995
- 1995-05-22 AU AU25312/95A patent/AU2531295A/en not_active Abandoned
- 1995-05-22 EP EP95919524A patent/EP0760680A1/en not_active Withdrawn
- 1995-05-22 JP JP8500478A patent/JPH10500982A/ja active Pending
- 1995-05-22 CA CA002190598A patent/CA2190598A1/en not_active Abandoned
- 1995-05-22 BR BR9507768A patent/BR9507768A/pt not_active Application Discontinuation
- 1995-05-22 WO PCT/GB1995/001152 patent/WO1995032737A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1995032737A1 (en) | 1995-12-07 |
CA2190598A1 (en) | 1995-12-07 |
AU2531295A (en) | 1995-12-21 |
JPH10500982A (ja) | 1998-01-27 |
EP0760680A1 (en) | 1997-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20004345L (no) | Farmasøytisk sammensetning | |
FI944832A (fi) | Farmaseuttinen koostumus | |
FI955311A (fi) | Farmaseuttinen koostumuspohja | |
ID18352A (id) | Komposisi-komposisi farmasi | |
ITMI932540A0 (it) | Composizione farmaceutica | |
BR9509688A (pt) | Composto e composição farmacêutica | |
BR9507768A (pt) | Composição farmacêutica | |
LV11727A (lv) | Farmaceitiska kompozicija | |
ID29294A (id) | Komposisi farmasi | |
FI973229A0 (fi) | Uusi farmaseuttinen koostumus | |
ITMI941169A0 (it) | Formulazioni farmaceutiche | |
ID18698A (id) | Komposisi farmasi | |
ID25857A (id) | Komposisi farmasi | |
ITMI942166A0 (it) | Composizioni farmaceutiche miorilassanti | |
FI973280A (fi) | Farmaseuttinen koostumus | |
LV10579A (lv) | Farmaceitiska kompozicija | |
FI951155A0 (fi) | Farmaseuttinen valmiste | |
ITMI962628A0 (it) | Composizione farmaceutica | |
FI962738A (fi) | Farmaseuttiset koostumukset | |
BR9605777A (pt) | Composição farmacêutica | |
ID23531A (id) | Komposisi farmasi | |
IT1272935B (it) | Composizione farmaceutica contenente n-acetil-cisteina | |
BR9605131A (pt) | Composição farmacêutica | |
SE9402924D0 (sv) | Novel pharmaceutical composition | |
BR9505130A (pt) | Composto e composiçao farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law |